Vicki Sato
InvestorVenture Partner at ARCH Venture Partners
Cambridge, Massachusetts
Writes $50K – $150M checks · typically $25M
Deals · 1
Syros Pharmaceuticals, Inc.Board seat
via ARCH Venture Partners · filed Feb 2018 · $11.4M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
Vir Biotechnology
Per SEC Form D filings.
Colleagues at ARCH Venture Partners
Ari Nowacek
Partner at ARCH Venture Partners
Ari Nowacek, M.D, Ph.D.
Partner at ARCH Venture Partners
Axel Bouchon
Venture Partner at ARCH Venture Partners
Axel Bouchon, Ph.D.
Venture Partner at ARCH Venture Partners
Brian Cuneo
Senior Partner at ARCH Venture Partners
Carol Suh
Partner at ARCH Venture Partners
Clinton Bybee
Co-founder & Managing Director, Emeritus at ARCH Venture Partners
Corey Ritter
Partner at ARCH Venture Partners
Frequently asked questions
- Who is Vicki Sato?
- Venture Partner at ARCH Venture Partners
- Where does Vicki Sato work?
- Vicki Sato is Venture Partner at ARCH Venture Partners.
- What check size does Vicki Sato write?
- Vicki Sato typically writes checks of $50K – $150M.
- What boards does Vicki Sato sit on?
- Vicki Sato holds tracked board seats at Syros Pharmaceuticals, Inc., Vir Biotechnology.




